Poly Medicure Ltd
POLYMEDPoly Medicure Ltd
POLYMEDPrice Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
89.60 | 17.97 | 0.11% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.70 | 6.31 | 0.52% |
Forecast & Ratings
Detailed Forecast from 6 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.
Peers
Compare with peersTarsons Products Ltd
Borosil Scientific Ltd
Balaxi Pharmaceuticals Ltd
Universus Photo Imagings Ltd
Constronics Infra Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 420.52 | 468.95 | 536.04 | 630.50 | 707.84 | 808.20 | 963.41 | 1,153.34 | 1,437.07 | 1,599.15 | ||||||||||
Raw Materials | 147.68 | 119.62 | 176.07 | 165.66 | 178.89 | 214.22 | 296.55 | 345.37 | 382.51 | 1,116.42 | ||||||||||
Power & Fuel Cost | 15.22 | 16.78 | 19.04 | 24.74 | 25.62 | 25.27 | 29.84 | 38.59 | 44.29 | |||||||||||
Employee Cost | 74.77 | 87.26 | 99.13 | 116.61 | 138.76 | 141.76 | 163.62 | 202.75 | 245.91 | |||||||||||
Selling & Administrative Expenses | 39.23 | 47.08 | 45.24 | 58.05 | 61.03 | 56.20 | 66.97 | 77.78 | 95.63 | |||||||||||
Operating & Other expenses | 47.61 | 90.80 | 58.98 | 114.53 | 116.82 | 132.53 | 151.07 | 183.34 | 246.97 | |||||||||||
EBITDA | 96.01 | 107.41 | 137.58 | 150.91 | 186.72 | 238.22 | 255.36 | 305.51 | 421.76 | 482.73 | ||||||||||
Depreciation/Amortization | 21.03 | 23.73 | 29.24 | 37.29 | 40.53 | 47.52 | 53.95 | 57.17 | 63.93 | 72.91 | ||||||||||
PBIT | 74.98 | 83.68 | 108.34 | 113.62 | 146.19 | 190.70 | 201.41 | 248.34 | 357.83 | 409.82 | ||||||||||
Interest & Other Items | 9.95 | 8.49 | 11.58 | 13.53 | 20.48 | 10.64 | 6.16 | 10.86 | 13.56 | 13.09 | ||||||||||
PBT | 65.03 | 75.19 | 96.76 | 100.09 | 125.71 | 180.06 | 195.25 | 237.48 | 344.27 | 396.73 | ||||||||||
Taxes & Other Items | 16.77 | 20.06 | 26.16 | 34.67 | 29.85 | 44.18 | 48.74 | 58.21 | 86.01 | 101.86 | ||||||||||
Net Income | 48.26 | 55.13 | 70.60 | 65.42 | 95.86 | 135.88 | 146.51 | 179.27 | 258.26 | 294.87 | ||||||||||
EPS | 5.47 | 6.25 | 8.00 | 7.41 | 10.86 | 14.76 | 15.28 | 18.69 | 26.91 | 30.72 | ||||||||||
DPS | 1.50 | 2.50 | 2.00 | 2.00 | 2.00 | 2.50 | 2.50 | 3.00 | 3.00 | 3.00 | ||||||||||
Payout ratio | 0.27 | 0.40 | 0.25 | 0.27 | 0.18 | 0.17 | 0.16 | 0.16 | 0.11 | 0.10 |
Company Updates
Peers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Poly Medicure Ltd | 102.30 | 17.97 | 0.11% |
Tarsons Products Ltd | 49.12 | 3.42 | 0.51% |
Borosil Scientific Ltd | 68.74 | 4.30 | — |
Balaxi Pharmaceuticals Ltd | -181.57 | 2.16 | — |
Price Comparison
Compare POLYMED with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 9.41%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.97%
Shareholding Pattern
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 1.05%
Top 5 Mutual Funds holding Poly Medicure Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.3160% | Percentage of the fund’s portfolio invested in the stock 3.33% | Change in the portfolio weight of the stock over the last 3 months 1.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/94 (+1) |
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8374% | Percentage of the fund’s portfolio invested in the stock 1.75% | Change in the portfolio weight of the stock over the last 3 months 0.54% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/70 (+3) |
SBI Healthcare Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6963% | Percentage of the fund’s portfolio invested in the stock 5.38% | Change in the portfolio weight of the stock over the last 3 months 5.38% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/33 (+29) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Poly Medicure Ltd
Events
Dividend Trend
No Dividend Cuts
POLYMED has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.11%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.09 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateSep 21, 2023
Dividend/Share
₹3.00
Ex DateEx Date
Sep 21, 2023
Cash Dividend
Ex DateEx DateSep 16, 2022
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹2.50
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateFeb 27, 2020
Dividend/Share
₹2.00
Ex DateEx Date
Feb 27, 2020
The stock soared 23.16% in the past three sessions, driven by strong Q2FY25 results announced on Tuesday (29 October 2024). On a consolidated basis, net profit of Poly Medicure rose 40.62% to Rs 87.45 crore on 24.53% increase in net sales to Rs 420.02 crore in Q2 September 2024 over Q2 September 2023. Profit before tax stood at Rs 117.98 crore in the Q1 FY25, up 45.7% YoY and up 19.83% QoQ. Operating profit margin (OPM) expanded to 27% in Q2 FY25, up from 25% in the same period last year. Poly Medicure manufactures disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets. Powered by Capital Market - Live
Net profit of Poly Medicure rose 40.62% to Rs 87.45 crore in the quarter ended September 2024 as against Rs 62.19 crore during the previous quarter ended September 2023. Sales rose 24.53% to Rs 420.02 crore in the quarter ended September 2024 as against Rs 337.29 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales420.02337.29 25 OPM %27.4624.97 - PBDT138.8496.94 43 PBT117.9880.95 46 NP87.4562.19 41 Powered by Capital Market - Live
Poly Medicure will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
Aptus Value Housing Finance India Ltd, J K Cements Ltd, Raymond Ltd, KSB Ltd are among the other stocks to see a surge in volumes on NSE today, 14 October 2024.Poly Medicure Ltd clocked volume of 5.74 lakh shares by 14:14 IST on NSE, a 9.61 times surge over two-week average daily volume of 59769 shares. The stock gained 2.60% to Rs.2,405.15. Volumes stood at 26617 shares in the last session.Aptus Value Housing Finance India Ltd registered volume of 158 lakh shares by 14:14 IST on NSE, a 7.68 fold spurt over two-week average daily volume of 20.59 lakh shares. The stock rose 8.41% to Rs.391.15. Volumes stood at 4.3 lakh shares in the last session.J K Cements Ltd recorded volume of 3.74 lakh shares by 14:14 IST on NSE, a 5.91 times surge over two-week average daily volume of 63179 shares. The stock gained 1.34% to Rs.4,295.75. Volumes stood at 54626 shares in the last session.Raymond Ltd saw volume of 12.09 lakh shares by 14:14 IST on NSE, a 4.45 fold spurt over two-week average daily volume of 2.72 lakh shares. The stock increased 4.71% to Rs.1,679.05. Volumes stood at 2.2 lakh shares in the last session.KSB Ltd notched up volume of 7.07 lakh shares by 14:14 IST on NSE, a 4.42 fold spurt over two-week average daily volume of 1.60 lakh shares. The stock rose 1.42% to Rs.918.90. Volumes stood at 1.34 lakh shares in the last session.Powered by Capital Market - Live
K E C International Ltd, TCI Express Ltd, Finolex Industries Ltd and Kalpataru Projects International Ltd are among the other losers in the BSE's 'A' group today, 20 September 2024.Poly Medicure Ltd lost 4.14% to Rs 2360.7 at 14:48 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 2464 shares were traded on the counter so far as against the average daily volumes of 6162 shares in the past one month.K E C International Ltd crashed 4.06% to Rs 945.5. The stock was the second biggest loser in 'A' group.On the BSE, 39389 shares were traded on the counter so far as against the average daily volumes of 99746 shares in the past one month.TCI Express Ltd tumbled 3.38% to Rs 1098. The stock was the third biggest loser in 'A' group.On the BSE, 3957 shares were traded on the counter so far as against the average daily volumes of 3975 shares in the past one month.Finolex Industries Ltd dropped 3.25% to Rs 297.7. The stock was the fourth biggest loser in 'A' group.On the BSE, 29463 shares were traded on the counter so far as against the average daily volumes of 63086 shares in the past one month.Kalpataru Projects International Ltd shed 3.24% to Rs 1334.6. The stock was the fifth biggest loser in 'A' group.On the BSE, 7214 shares were traded on the counter so far as against the average daily volumes of 15645 shares in the past one month.Powered by Capital Market - Live
Poly Medicure announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
The company has allotted 53.19 equity shares to qualified institutional investors, the shares were priced at Rs 1,880 apiece, resulting in an issue size of approximately Rs 1,000 crore. The QIP garnered interest from a diverse range of investors, including long-only funds, mutual funds, insurance companies, and other key stakeholders. The QIP witnessed participation from various institutional investors, with the allottees receiving more than 5% of the total issue size. Lighthouse India Fund received 20% allocation from the total issue, followed by SBI Mutual Fund (13%) and Nomura Funds Ireland (10.50%), Further, ICICI Prudential Life Insurance Company, Kotak Mahindra Life Insurance Company, Quant Mutual Fund, Max Life Insurance Company received an allocation of 5% each. Poly Medicure intends to use the proceeds from the issue for funding capital expenditure to be incurred by the company for setting up of manufacturing facilities, pursuing inorganic initiatives; and general corporate purposes. Poly Medicure manufactures disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets. Powered by Capital Market - Live
Poly Medicure has launched a qualified institutional placement of equity shares of face value of Rs 5 each with floor price of Rs 1880.6875 per equity share on 19 August 2024. Powered by Capital Market - Live
Board of Poly Medicure appoints director
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 17.91%, vs industry avg of 16.09%
Decreasing Market Share
Over the last 5 years, market share decreased from 55.46% to 48.27%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 31.6%, vs industry avg of -8.51%